|
|
|
|
|
|
|
Company Background
|
|
|
|
|
Cohance Lifesciences Ltd.
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
BSE Code |
543064
|
|
ISIN Demat |
INE03QK01018
|
|
Book Value |
117.11
|
|
|
NSE Code |
COHANCE
|
|
Dividend Yield % |
0.00
|
|
Market Cap |
162265.85
|
|
|
P/E |
70.95
|
|
EPS |
5.98
|
|
Face Value |
1
|
|
|
|
|
|
|
|
|
|
|
|
Incorporation Year
|
06-11 2018
|
|
Registered Office
|
215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc, Mumbai,
Maharashtra-400093 .
|
|
ISINNO
|
INE03QK01018
|
|
Phone
|
022-61539999
|
|
E-mail
|
info@suvenpharm.com |
|
URL
|
www.cohance.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
|
|
Managing Director
|
|
|
Company Secretary
|
Sisir K Mishra
|
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|